NYU Langone Health experts will join colleagues from around the world at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting.

With more than 65 presentations, our faculty and trainees will showcase advances across several high-impact areas in cancer care, including:

  • KRAS-targeted research
  • Innovations in lung and pancreatic cancer treatment
  • New long-term findings from the KEYNOTE-942 melanoma study

Below are notable sessions featuring our faculty and trainees, along with links to complete daily schedules of sessions featuring NYU Langone specialists.

Friday, May 29

View the complete list of Friday sessions featuring NYU Langone specialists.

Saturday, May 30

Rapid Oral Abstract
Abstract 8520: DZD6008, a fourth-generation EGFR TKI in pretreated NSCLC patients with EGFR C797X mutations: Results from phase 1/2 studies.
Session: Lung Cancer—Non-Small Cell Metastatic
NYU Langone Co-Author: Elaine Shum, MD
Time: 2:27–2:33PM
Location: Hall D2

Poster
Abstract 3109: First-in-human phase 1/2 study of ETX-19477, an oral, potent, and selective PARG inhibitor, in patients with advanced solid tumors (ERADIC8)
Session: Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
NYU Langone Co-Author: Nancy Chan, MD
Time: 1:30–4:30PM
Location: Hall A – Posters and Exhibits

View the complete list of Saturday sessions featuring NYU Langone specialists.

Sunday, May 31

Rapid Oral Abstract
Abstract 7513: Daratumumab plus bortezomib, lenalidomide, and dexamethasone (DVRd) in patients (pts) with newly diagnosed multiple myeloma (NDMM): Final analysis of transplant-ineligible (TIE) pts in the phase 3 CEPHEUS study
Session: Hematologic Malignancies—Plasma Cell Dyscrasia
NYU Langone Co-Author: Marc J. Braunstein, MD, PhD
Time: 10:21–10:27AM
Location: E450a

Plenary Presentation
Abstract LBA5: Daraxonrasib, a RAS(ON) multi-selective inhibitor vs chemotherapy in previously treated metastatic pancreatic adenocarcinoma (mPDAC): Primary and final analysis from the phase 3 RASolute 302 study
Session: Plenary Session
NYU Langone Co-Author: Paul E. Oberstein, MD
Time: 3:21–3:33PM
Location: Hall B1

Poster
Abstract 5074: Dissecting metastatic castration-resistant prostate cancer using regulatory network analysis of tumor transcriptomes
Session: Genitourinary Cancer—Prostate, Testicular, and Penile
Presenter: Aaron Griffin, MD
NYU Langone Senior Author: David R. Wise, MD, PhD
Time: 9:00AM–12:00PM
Location: Hall A – Posters and Exhibits

Poster
Abstract 8072: Trends in Income-related lung cancer disparities since the introduction of the USPSTF Screening Guidelines
Session: Lung Cancer—Non-small cell local-regional/small cell/other thoracic cancers
Presenter: Tyler M. Healy, MD
NYU Langone Senior Author: Daniel J. Becker, MD
Time: 9:00AM–12:00PM
Location: Hall A – Posters and Exhibits

Poster
Abstract 8568: Efficacy, safety, and cytokine profiling with addition of the toll-like receptor (TLR) 7/8 dual agonist EIK1001 to standard of care (SOC) first-line (1L) therapy: The phase 2 TeLuRide-005 trial in stage 4 NSCLC.
Session: Lung Cancer—Non-Small Cell Metastatic
NYU Langone Co-Author: Marissa Rybstein, MD
Time: 9:00AM–12:00PM
Location: Hall A – Posters and Exhibits

Poster
Abstract 8579: Initial safety and efficacy of A2B694, a logic-gated mesothelin (MSLN)–targeted Tmod chimeric antigen receptor T-cell (CAR T) therapy in patients with advanced solid tumors with HLA-A*02 loss of heterozygosity (LOH)
Session: Lung Cancer—Non-Small Cell Metastatic
NYU Langone Senior Author: Salman R. Punekar, MD
Time: 9:00AM–12:00PM
Location: Hall A – Posters and Exhibits

Poster
Abstract 8614: COPERNICUS, a pragmatic phase 2b study of subcutaneous (SC) amivantamab (ami) + chemotherapy (chemo) with enhanced dermatologic adverse event (AE) prophylaxis in EGFR-mutated advanced NSCLC: Interim results
Session: Lung Cancer—Non-Small Cell Metastatic
NYU Langone Co-Author: Joshua K. Sabari, MD
Time: 9:00AM–12:00PM
Location: Hall A – Posters and Exhibits

View the complete list of Sunday sessions featuring NYU Langone specialists.

Monday, June 1

Oral Abstract
Abstract 9500: Individualized neoantigen therapy intismeran autogene (intismeran) plus pembrolizumab (pembro) in resected melanoma: 5-year update of the KEYNOTE-942 study.
Session: Melanoma/Skin Cancers
NYU Langone Senior Author: Janice Mehnert, MD
Time: 8:00–8:12AM
Location: S100bc

Oral Abstract
Abstract LBA9505: Updated outcomes from STAMP: Surgically treated adjuvant Merkel cell carcinoma with pembrolizumab, a phase III trial—ECOG-ACRIN EA6174.
Session: Melanoma/Skin Cancers
Presenter: Janice Mehnert, MD
Time: 9:36–9:48AM
Location: S100bc

Rapid Oral Abstract
Abstract 4012: Randomized phase II trial of olaparib and pembrolizumab vs olaparib alone as maintenance therapy in metastatic pancreatic cancer patients with germline BRCA1 or BRCA2 (gBRCA1/2) mutations: SWOG S2001
Session: Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
NYU Langone Co-Author: Rafael Winograd, MD, PhD
Time: 1:00–1:15PM
Location: Hall D2

Poster
Abstract 6529: Preliminary results of an open-label, single-arm phase 2/3 trial (SPARK-ALL) of calaspargase pegol in adults with newly diagnosed Philadelphia chromosome–negative acute lymphoblastic leukemia
Session: Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant
NYU Langone Co-Author: Mohammad Maher Abdul Hay, MD
Time: 9:00AM–12:00PM
Location: Hall A – Posters and Exhibits

Poster
Abstract 7065: Frontline intensified vs standard immunochemotherapy in high-risk diffuse large B-cell lymphoma: A systematic review and meta-analysis.
Session: Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia
Presenter: Lauren Scarpetti, MD
NYU Langone Senior Author: Samuel Yamshon, MD
Time: 9:00AM–12:00PM
Location: Hall A – Posters and Exhibits

Poster
Abstract 594: Association of immunotherapy infusion timing with outcomes in early-stage triple-negative breast cancer.
Session: Breast Cancer—Local/Regional/Adjuvant
Presenter: Xianghui Zou, MD
NYU Langone Senior Author: Iris Zhi, MD, PhD
Time: 1:30–4:30PM
Location: Hall A – Posters and Exhibits

View the complete list of Monday sessions featuring NYU Langone specialists.